A drug undergoing clinical trials for sleeping sickness could also treat leishmaniasis, say researchers who have tested it on mice.

Unprecedented collaboration by drug firms, ambitious targets and more funds form part of a new fight against neglected tropical diseases.

Pacific islanders are at much higher risk of ciguatera fish toxins than previously thought, and the number of sufferers is increasing.

A modelling study of a promising malaria vaccine finds low transmission areas would benefit the most from mass vaccination.

The key malaria drug, artemisinin, can now be produced in greater quantities ― from a waste material of the current production process.

Indian health officials are describing hard to treat cases of TB as 'extra XDR-TB' amid warnings that the disease is not being managed properly.

Indigenous women have a higher risk of bad health than those from other poor or urban communities, says a study in Honduras.

A new formulation of benznidazol, at a dose suitable for children, will be produced and distributed at cost for Latin American countries.

Acting fast with the right antivenom following a bite from a dangerous snake could be easier with a new dipstick test, researchers say.

High-tech healthcare from rich countries is distracting Africa from more powerful uses of e-health, a conference in Kenya has heard.

A big cut in donor commitments to the global health fund has forced the agency to cancel new programmes.

Diagnosis and treatment of patients with mild symptoms of dengue fever in special tents unburdened hospitals during the 2008 epidemics in Rio.

Joining forces would save countries money on clinical trials, and speed up drug development for neglected diseases, says a report.

An initiative launched by major patent holders will improve access to neglected disease research, but only 49 countries will freely benefit.

Researchers have created a database of the chemicals in 300 Chinese herbs used in traditional medicine.

The only manufacturer of benzonidazol, a drug for Chagas disease, is failing to meet the demand, affecting patient’s access to therapy.

Pakistan’s struggle to contain its polio cases has been crippled by floods, conflict and poor awareness.

Indian company Aurobindo Pharma will manufacture several antiretroviral medicines licensed to the Medicines Patent Pool.

Results from phase III clinical trials in Africa show a vaccine protects children from malaria, but with a modest efficacy.

A panel including Nobel laureate economists has said that vaccine research is the biggest HIV/AIDS funding priority.